ICOS International Cardio-Oncology Society
Cancer and cardiovascular disease (CVD) are the two most common causes of death and disease worldwide! The incidence of both cancer and cardiovascular disease increases with age. With increased life expectancy, the burden of both diseases will increase substantially over the next decade. Also, advancement in cancer therapy and supportive care has led to an increasing number of survivors of childhood cancer. childhood cancer Seventy percent of the children diagnosed with malignancy before the age of 15 years will have a disease-free 5-year survival from diagnosis. Cancer is now being recognized as a chronic disease, as evidenced by a growing number of cancer survivors that currently exceeds 11 million. With further improvement in cancer therapy, this number will likely increase in years to come.
What is Cardio-Oncology?
IC-OS Board Review Book
IC-OS Board Review Book now available
Table of Contents:
- Basic Pharmacology
- Surveillance and Survivorship
- Treatment-Related Cardiotoxicity
- Electrophysiology and Cardio-Oncology
- Radiation-Induced Heart Disease
- Anticoagulation: Thromboprophylaxis and Treatment
- Rare Conditions and Syndromes
- Clinical Case Challenges
- Common Chemotherapy Regimen Acronyms
Weekly Webinars Now Available
- First Thursday of the month : Journal Club
- Second Thursday of the month : Case Reviews
- Third Thursday of the month : Covid-19 Cardio-Oncology Issues
- Fourth Thursday of the month : Topics in Cardio-Oncology
Cardio-Oncology is now the official journal of ICOS
This partnership will expand and advance the understanding of cardiac complications of cancer treatments by providing ICOS members a platform for publication of original, peer-reviewed articles in the emerging field of study and research in cardio-oncology.Learn More
Taking Survival To Heart
Eliminate cardiac disease as a barrier to effective cancer therapy in all of our patients being treated or who were previously treated for cancer.
ICOS exists to advance cardiovascular care of cancer patients and survivors by promoting collaboration among researchers, educators and clinicians around the world.
NO ONE HAS EVER BECOME POOR BY GIVING
Why does there need to be a focus on CardioOncology?
The complexity of contemporary cancer treatment has risen dramatically and patients are surviving even longer than ever before. As a result, cardiac disease comes to the forefront of long term survivorship.
Why donate time, energy, and money to the cause?
True multidisciplinary approaches to medical care are always valued and have dramatic improvements in overall outcomes.Donate Now
Personalised management of Prostate Cancer patients with history and risk of CVD events
Module 2: Debate – How to manage CVD risk in PCa patients during COVID 19
- Wednesday, 7 April 2021, 18:30 – 19:30 CET
Moderator: Prof. P-A. Abrahamsson (SE)
Presenter: Prof. A. Ghosh (GB) – “Impact of COVID-19 on cardio-oncology”
Dr. M. Linch (GB) – “Hormonal treatment of urological cancers during COVID-19”
Dr. R.A. Rendon (CA) – “How to manage prostate cancer in a pandemic”
Prof. Dr. M.J. Ribal Caparros (ES) – “COVID-19 Recommendations for Prostate Cancer treatment by the EAU Guidelines”
All Things Cardio Oncology
Here is a resource for expanding your understanding of the growing field of cardio oncology in all its dimensionsListen Here
Wherever you get your podcasts